Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Circulation. Cardiovascular Interventions
|
July 29, 2021
Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
Rim Halaby, Jay Giri, Howard C Herrmann, et al.
American Journal of Nephrology
|
February 10, 2015
Renal function decline in recipients and donors of kidney grafts: role of aortic stiffness
Sola Aoun Bahous, Maya Khairallah, Jad Al Danaf, et al.
American Heart Journal
|
January 14, 2023
Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial
Alexander C Fanaroff, Samantha Coratti, Rim Halaby, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 6, 2015
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need
Serge Korjian, Yazan Daaboul, Rim Halaby, et al.
JAMA Cardiology
|
July 26, 2023
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review
Kriyana P Reddy, Michela Faggioni, Lauren A Eberly, et al.
Current Cardiology Reports
|
September 12, 2013
Is there a need for "triple therapy"? Role of anticoagulation with dual antiplatelet therapy in acute coronary syndromes (ATLAS Study & TRAP Study)
William L Patrick, Charmaine Patel, Raviteja Guddeti, et al.
Circulation
|
November 25, 2016
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)
C Michael Gibson, Gerald Chi, Rim Halaby, et al.
European Heart Journal
|
November 21, 2015
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention
C Michael Gibson, Robert P Giugliano, Robert A Kloner, et al.
JACC. Cardiovascular Interventions
|
April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial
Rim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
June 29, 2019
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial
C Michael Gibson, Lisa K Jennings, Gerald Chi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Circulation. Cardiovascular Interventions
|
July 29, 2021
Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
Rim Halaby, Jay Giri, Howard C Herrmann, et al.
American Journal of Nephrology
|
February 10, 2015
Renal function decline in recipients and donors of kidney grafts: role of aortic stiffness
Sola Aoun Bahous, Maya Khairallah, Jad Al Danaf, et al.
American Heart Journal
|
January 14, 2023
Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial
Alexander C Fanaroff, Samantha Coratti, Rim Halaby, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 6, 2015
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need
Serge Korjian, Yazan Daaboul, Rim Halaby, et al.
JAMA Cardiology
|
July 26, 2023
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review
Kriyana P Reddy, Michela Faggioni, Lauren A Eberly, et al.
Current Cardiology Reports
|
September 12, 2013
Is there a need for "triple therapy"? Role of anticoagulation with dual antiplatelet therapy in acute coronary syndromes (ATLAS Study & TRAP Study)
William L Patrick, Charmaine Patel, Raviteja Guddeti, et al.
Circulation
|
November 25, 2016
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)
C Michael Gibson, Gerald Chi, Rim Halaby, et al.
European Heart Journal
|
November 21, 2015
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention
C Michael Gibson, Robert P Giugliano, Robert A Kloner, et al.
JACC. Cardiovascular Interventions
|
April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial
Rim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
June 29, 2019
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial
C Michael Gibson, Lisa K Jennings, Gerald Chi, et al.
Page
of 3